Citadel Advisors »

Oncocyte Corporation shares owned by Citadel Advisors

Quarter-by-quarter ownership of Oncocyte Corporation (IMDX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $41k 12k 3.50
2025-06-30 $93k 31k 3.02
2025-03-31 $149k 49k 3.06

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Oncocyte Corporation

Broadwood Capital
AWM Investment Company
Pura Vida Investments
Vanguard Group
Geode Capital Management
BlackRock
Millennium Management
Morgan Stanley
State Street Corporation
Northern Trust
FNY Investment Advisers
Renaissance Technologies
Citadel Advisors
Advisor Group Holdings
Private Advisor

View all funds holding Oncocyte Corporation